US team makes tool to access microarray technologies
This article was originally published in Clinica
Executive Summary
A US researcher team has developed a tool that commercial companies can use to assess the accuracy of their new microarray technologies". The tool is a study framework, similar to the microarray quality control (MAQC) project set up by the US FDA, but the researchers, based at the Department of Genetics at Harvard Medical School, believe that their framework is "more comprehensive".